Appili Therapeutics Inc. (TSX:APLI)

Canada · Delayed Price · Currency is CAD

0.0150

-0.0050 (-25.00%)

At close: Mar 20, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Biotechnology (Startups)	100.44K	827.41K	334.18K	1.39M		199.11K
Biotechnology (Startups) Growth	-87.86%	147.60%	-75.97%	-		-
Total	100.44K	827.41K	334.18K	1.39M		199.11K
Total Growth	-87.86%	147.60%	-75.97%	-		-

Revenue by Geography

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Canada	100.44K	827.41K	334.18K	1.39M		199.11K
Canada Growth	-87.86%	147.60%	-75.97%	-		-
Total	100.44K	827.41K	334.18K	1.39M		199.11K
Total Growth	-87.86%	147.60%	-75.97%	-		-

Source: S&P Global Market Intelligence.